NeoGenomics
NEO
#5805
Rank
โ‚ฌ0.99 B
Marketcap
7,65ย โ‚ฌ
Share price
6.08%
Change (1 day)
8.50%
Change (1 year)

Revenue for NeoGenomics (NEO)

Revenue in 2026 (TTM): โ‚ฌ0.63 Billion

According to NeoGenomics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.64 Billion. In 2025 the company made a revenue of โ‚ฌ0.61 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ0.63 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for NeoGenomics from 2000 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.63 B2.89%
2025 โ‚ฌ0.61 B-2.46%
2024 โ‚ฌ0.63 B18.61%
2023 โ‚ฌ0.53 B12.63%
2022 โ‚ฌ0.47 B11.11%
2021 โ‚ฌ0.42 B18.35%
2020 โ‚ฌ0.36 B-0.99%
2019 โ‚ฌ0.36 B50.86%
2018 โ‚ฌ0.24 B17.69%
2017 โ‚ฌ0.20 B-11.42%
2016 โ‚ฌ0.23 B154.23%
2015 โ‚ฌ91.27 M27.5%
2014 โ‚ฌ71.58 M48.74%
2013 โ‚ฌ48.12 M6.34%
2012 โ‚ฌ45.25 M35.17%
2011 โ‚ฌ33.48 M29.58%
2010 โ‚ฌ25.84 M25.63%
2009 โ‚ฌ20.56 M43.67%
2008 โ‚ฌ14.31 M81.7%
2007 โ‚ฌ7.87 M60.54%
2006 โ‚ฌ4.9 M208.38%
2005 โ‚ฌ1.59 M286.85%
2004 โ‚ฌ0.41 M40%
2003 โ‚ฌ0.29 M
2000 โ‚ฌ0.26 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Quest Diagnostics
DGX
โ‚ฌ9.69 B 1,411.86%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ12.15 B 1,796.08%๐Ÿ‡บ๐Ÿ‡ธ USA
RadNet
RDNT
โ‚ฌ1.75 B 173.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
โ‚ฌ16.92 M-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚ฌ23.61 M-96.32%๐Ÿ‡บ๐Ÿ‡ธ USA